Ho AL - Search Results

1

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.

Ho AL, Grewal RK, Leboeuf R, Sherman EJ, Pfister DG, Deandreis D, Pentlow KS, Zanzonico PB, Haque S, Gavane S, Ghossein RA, Ricarte-Filho JC, Domínguez JM, Shen R, Tuttle RM, Larson SM, Fagin JA. Ho AL, et al. N Engl J Med. 2013 Feb 14;368(7):623-32. doi: 10.1056/NEJMoa1209288. N Engl J Med. 2013. PMID: 23406027 Free PMC article. Clinical Trial.

2

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.

Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG. Laurie SA, et al. Among authors: ho al. Lancet Oncol. 2011 Aug;12(8):815-24. doi: 10.1016/S1470-2045(10)70245-X. Epub 2010 Dec 10. Lancet Oncol. 2011. PMID: 21147032 Review.

3

Clinical development of kinase inhibitors for the treatment of differentiated thyroid cancer.

Ho AL, Sherman E. Ho AL, et al. Clin Adv Hematol Oncol. 2011 Jan;9(1):32-41. Clin Adv Hematol Oncol. 2011. PMID: 21326144 Review.

4

Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review.

Sherman EJ, Lim SH, Ho AL, Ghossein RA, Fury MG, Shaha AR, Rivera M, Lin O, Wolden S, Lee NY, Pfister DG. Sherman EJ, et al. Among authors: ho al. Radiother Oncol. 2011 Dec;101(3):425-30. doi: 10.1016/j.radonc.2011.09.004. Epub 2011 Oct 6. Radiother Oncol. 2011. PMID: 21981877

5

A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.

Fury MG, Sherman E, Ho AL, Xiao H, Tsai F, Nwankwo O, Sima C, Heguy A, Katabi N, Haque S, Pfister DG. Fury MG, et al. Among authors: ho al. Cancer. 2013 May 15;119(10):1823-31. doi: 10.1002/cncr.27986. Epub 2013 Feb 13. Cancer. 2013. PMID: 23408298 Free PMC article. Clinical Trial.

6

Inhibition of mutant GNAQ signaling in uveal melanoma induces AMPK-dependent autophagic cell death.

Ambrosini G, Musi E, Ho AL, de Stanchina E, Schwartz GK. Ambrosini G, et al. Among authors: ho al. Mol Cancer Ther. 2013 May;12(5):768-76. doi: 10.1158/1535-7163.MCT-12-1020. Epub 2013 Feb 26. Mol Cancer Ther. 2013. PMID: 23443802

7

Moving toward a better understanding of radioiodine action.

Ho AL. Ho AL. Endocrine. 2013 Dec;44(3):553-4. doi: 10.1007/s12020-013-0024-x. Epub 2013 Aug 30. Endocrine. 2013. PMID: 23990267 No abstract available.

8

A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer.

Fury MG, Lee NY, Sherman E, Ho AL, Rao S, Heguy A, Shen R, Korte S, Lisa D, Ganly I, Patel S, Wong RJ, Shaha A, Shah J, Haque S, Katabi N, Pfister DG. Fury MG, et al. Among authors: ho al. Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):479-86. doi: 10.1016/j.ijrobp.2013.06.2043. Int J Radiat Oncol Biol Phys. 2013. PMID: 24074921 Clinical Trial.

9

A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer.

Ho AL, Lipson BL, Sherman EJ, Xiao H, Fury MG, Apollo A, Seetharamu N, Sima CS, Haque S, Lyo JK, Sales R, Cox L, Pfister DG. Ho AL, et al. Invest New Drugs. 2014 Jun;32(3):549-54. doi: 10.1007/s10637-014-0073-x. Epub 2014 Feb 25. Invest New Drugs. 2014. PMID: 24566705 Clinical Trial.

10

Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study.

Nagarajah J, Ho AL, Tuttle RM, Weber WA, Grewal RK. Nagarajah J, et al. Among authors: ho al. J Nucl Med. 2015 May;56(5):662-7. doi: 10.2967/jnumed.114.150607. Epub 2015 Mar 26. J Nucl Med. 2015. PMID: 25814520 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters